Oric Pharmaceuticals stock rises 3.2% today, trading at $12.72 while the company prepares to review enozertinib trial data.
Governor Abigail Spanberger today — in expert testimony filed with the State Corporation Commission (SCC) on behalf of the ...
This story was a collaboration between Inside Climate News and the San Antonio Express-News. SAN ANTONIO—In Texas, suburbs ...
KBRA's latest surveillance report examines ABS performance and risk across auto, equipment, solar, and marketplace consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results